Latest Breaking News On - Silo pharma inc - Page 15 : comparemela.com

Silo Pharma Engages Clarivate for Intellectual Property and Patent Management

Clarivate will monitor, manage, and maintain Company’s expanding IP portfolio ENGLEWOOD CLIFFS, NJ, Aug. 10, 2023 Silo Pharma, Inc. , a developmental stage biopharmaceutical company. -Today at 08:50 am- MarketScreener

San-francisco
California
United-states
Eric-weisblum
Silo-pharma-inc
Columbia-university
University-of-california
University-of-maryland
Globenewswire-inc
Nasdaq
Therapeutics-inc
Silo-pharma

InvestorNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Announces Strategic Engagement to Step up IP and Patent Expansion Efforts

InvestorNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Announces Strategic Engagement to Step up IP and Patent Expansion Efforts
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Los-angeles
Eric-weisblum
Silo-pharma-inc
Silo-pharma
Blvd-suite

Silo Pharma Reaches Positive Milestone with Nasal Formulation of SPC-15 For Anxiety, PTSD, and Stress-Related Disorders

Silo Pharma Reaches Positive Milestone with Nasal Formulation of SPC-15 For Anxiety, PTSD, and Stress-Related Disorders
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Eric-weisblum
Silo-pharma-inc
Columbia-university
Nasdaq
Chief-executive-officer
Silo-pharma
Looking-statements

Silo Pharma (SILO) Reaches Positive Milestone with Nasal Formulation of SPC-15 For Anxiety, PTSD, and Stress-Related Disorders

Silo Pharma (SILO) Reaches Positive Milestone with Nasal Formulation of SPC-15 For Anxiety, PTSD, and Stress-Related Disorders
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Eric-weisblum
Silo-pharma-inc
Nasdaq
Columbia-university
Silo-pharma
Chief-executive-officer

Silo Pharma, Inc. (NASDAQ:SILO) Short Interest Update

Silo Pharma, Inc. (NASDAQ:SILO – Get Free Report) was the recipient of a significant decrease in short interest in the month of June. As of June 30th, there was short interest totalling 32,900 shares, a decrease of 82.7% from the June 15th total of 190,500 shares. Currently, 1.3% of the shares of the company are […]

Silo-pharma-inc
Silo-pharma-company-profile
Nasdaq
Geode-capital-management
Silo-pharma
Get-free-report
Street-corp
Advocates-investment-management
Silo-pharma-daily
Nasdaq-silo
Silo